On Monday, September 16, the next meeting of the Transparency Council.
AOTMiT: Transparency Council on hemiplegia and ADHD, among others
Published Sept. 16, 2024 08:53
Źródło: AOTMiT
The agenda includes:
1 Prepare a position paper on the evaluation of the drug Takhzyro (lanadelumabum) within the framework of the drug program "Preventive treatment of patients with recurrent attacks of severe hereditary angioedema".
2 Prepare a position paper on the legitimacy of issuing approvals for reimbursement of the medicinal product Adderall XR (amphetamine + dextroamphetamine) for the indication: in the treatment of attention deficit hyperactivity disorder (ADHD) (ICD-10: F90.1).
3 Prepare an opinion on the draft health policy program of the local government unit "Prevention of herpes zoster and postherpetic neuralgia by vaccination of residents of Poznań aged at least 18 years with risk factors and 50 years and older for 2025-2027".
4 Prepare an opinion on the draft health policy program of the local government unit "Prevention of herpes zoster and postherpetic neuralgia by vaccination of residents of Poznań aged 65 and older with an increased risk of developing herpes zoster for 2025-2027".
5 Prepare an opinion on the continuation of coverage of the active substance colecalciferolum in the indication: chronic kidney disease.
Source: AOTMiT
